Renewed assessment of the risk of emergent advanced cell therapies to transmit neuroproteinopathies

Authors: A Aguzzi
A Bellon
A Fenyi
A Miranda
A Peden
A Serio
A Trounson
AB Tullo
AI Caplan
Alison Green
AWP Fitzpatrick
B Babelhadj
C Duyckaerts
C Hetz
C Lacroux
CD Orru
CN Svendsen
Committee UHoCSaT
D Herve
D Kalladka
Diane Ritchie
DJ Irwin
DL Ritchie
DM Taylor
E Gonzalo-Gil
E Monni
EA Miljan
F Clavaguera
F Moda
G Edgren
G Fairfoul
GG Kovacs
GI Nistor
H Fraser
H Guenou
HM Yang
I Cali
J Candiello
J Galipeau
J Hope
J Lewis
J Rasmussen
J Yuan
JA Thomson
JC Watts
JY Li
K Frontzek
K Murray
K Takahashi
KC Luk
L Bousset
L Concha-Marambio
L Cruz da
L Ferrer
L Waddell
LI McGuire
M Meyer-Luehmann
M Shahnawaz
MA Barria
Mark W. Head
MF Pittenger
MM Adil
MW Head
MW Head
N Salvadores
NJ Hart
ON Gill
P Brown
P Rudge
Paul A. De Sousa
PJ Urwin
R Gadkari
Richard Knight
S Grealish
S Halliez
S Mardpour
SA Rosenberg
SB Prusiner
SB Prusiner
SD Schwartz
SD Schwartz
SD Schwartz
Siddharthan Chandran
SL Benestad
T Hamaguchi
T Uchihara
W Zhang
Y Koronyo
YS Eisele
YS Eisele
Z Jaunmuktane
Z Jaunmuktane
Z Krejciova
Z Krejciova
Publication date: 27 November 2018
Publisher: 'Springer Science and Business Media LLC'
Doi

Abstract

Abstract is not available.

Similar works

Full text

thumbnail-image

Open in the Core reader

Available Versions

Edinburgh Research Explorer

redirect

oai:pure.ed.ac.uk:publications...

Last time updated on 11/05/2020

Crossref

redirect

Last time updated on 25/10/2020